Abstract
Purpose
The elderly often use several drugs on a regular basis and are especially at risk for drug-related harm from side effects and interactions. The aim of this study was to explore the overall prevalence of and predictors for potentially inappropriate medication use among Norwegian elderly outpatients.
Methods
A pharmaco-epidemiological retrospective cross-sectional survey was undertaken based on data from the Norwegian Prescription Database. Prescriptions from all doctors in Norway, dispensed by pharmacies to home-dwelling elderly ≥70 years in 2008, were included for a total of 11,491,065 prescriptions from 24,540 prescribers to 445,900 individuals (88.3% of the Norwegian population in this age group, 58.9% females). We applied a list of criteria for pharmacological inappropriateness for elderly people (the NORGEP criteria) to determine the prevalence of potentially inappropriate medications (PIMs) and applied a multiple logistic regression model to identify predictors.
Results
According to our criteria, 34.8% of the study population (28.5% of the men, 39.3% of the women) was exposed to at least one PIM. Of these, 59.9% represented psychoactive substances. The odds of receiving potentially harmful prescriptions increased with the number of prescribers (OR 3.52, 99% CI 3.44–3.60 for those with ≥5 compared to those with 1 or 2 prescribers). Twenty percent were prescribed more than 10 medications; among these two-thirds had at least one PIM. Adjusted for differences in age distribution and the number of prescribers involved, women were more frequently exposed to PIMs than men, with an odds ratio of 1.60 (99% CI 1.58–1.64).
Conclusions
About one-third of the elderly Norwegian population is exposed to potentially inappropriate medications, and elderly females are at particular risk.
Similar content being viewed by others
References
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329(7456):15–19. doi:10.1136/bmj.329.7456.15
Wester K, Jonsson AK, Spigset O, Druid H, Hagg S (2008) Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 65(4):573–579. doi:10.1111/j.1365-2125.2007.03064.x
Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279(15):1200–1205
Ebbesen J, Buajordet I, Erikssen J, Brors O, Hilberg T, Svaar H, Sandvik L (2001) Drug-related deaths in a department of internal medicine. Arch Intern Med 161(19):2317–2323. doi:ioi00941
Viktil KK, Blix HS, Moger TA, Reikvam A (2007) Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 63(2):187–195. doi:10.1111/j.1365-2125.2006.02744.x
Lapi F, Pozzi C, Mazzaglia G, Ungar A, Fumagalli S, Marchionni N, Geppetti P, Mugelli A, Di Bari M (2009) Epidemiology of suboptimal prescribing in older, community dwellers: a two-wave, population-based survey in Dicomano, Italy. Drugs Aging 26(12):1029–1038. doi:10.2165/11319390-000000000-00000
Rønning M, Berg C, Furu K, Litleskare I, Mahic M, Sakshaug S, Selmer R, Strøm H (2009) The Norwegian Prescription Database 2004–2008. Norwegian Institute of Public Health, Oslo
Garfinkel D, Mangin D (2010) Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 170(18):1648–1654. doi:10.1001/archinternmed.2010.355
Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG (2008) Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 25(12):1021–1031. doi:10.2165/0002512-200825120-00004
Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham BG, Harris TB, Hanlon JT, Rubin SM, Shorr RI, Bauer DC, Abernethy DR (2007) A drug burden index to define the functional burden of medications in older people. Arch Intern Med 167(8):781–787. doi:10.1001/archinte.167.8.781
Grahame-Smith DG, Aronson JK (eds) (2002) Oxford textbook of clinical pharmacology and drug therapy, 3rd edn. Oxford University Press, Oxford
Gerretsen P, Pollock BG (2011) Drugs with anticholinergic properties: a current perspective on use and safety. Expert Opin Drug Saf 10(5):751–765. doi:10.1517/14740338.2011.579899
Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, Coulton S, Katona C, Boustani MA, Brayne C (2011) Anticholinergic medication use and cognitive impairment in the older population: the Medical Research Council Cognitive Function and Ageing Study. J Am Geriatr Soc 59(8):1477–1483. doi:10.1111/j.1532-5415.2011.03491.x
Aizenberg D, Sigler M, Weizman A, Barak Y (2002) Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr 14(3):307–310
Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE (2008) The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 168(5):508–513. doi:10.1001/archinternmed.2007.106
Page J, Henry D (2000) Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 160(6):777–784
Blix HS, Viktil KK, Moger TA, Reikvam A (2006) Use of renal risk drugs in hospitalized patients with impaired renal function–an underestimated problem? Nephrol Dial Transplant 21(11):3164–3171. doi:10.1093/ndt/gfl399
Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA (1991) Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114(4):257–263
Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J (2001) Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 158(6):892–898
Pariente A, Dartigues JF, Benichou J, Letenneur L, Moore N, Fourrier-Reglat A (2008) Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 25(1):61–70
Chang CB, Chan DC (2010) Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging 27(12):947–957. doi:10.2165/11584850-000000000-00000
Dimitrow MS, Airaksinen MS, Kivela SL, Lyles A, Leikola SN (2011) Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J Am Geriatr Soc 59(8):1521–1530. doi:10.1111/j.1532-5415.2011.03497.x
Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157(14):1531–1536
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163(22):2716–2724. doi:10.1001/archinte.163.22.2716
Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151(9):1825–1832
Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D (2008) STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 46(2):72–83
Aparasu RR, Mort JR (2000) Inappropriate prescribing for the elderly: Beers criteria-based review. Ann Pharmacother 34(3):338–346
van der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, van der Cammen TJ, Stricker BH, Sturkenboom MC (2005) Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria—a population-based cohort study. Br J Clin Pharmacol 60(2):137–144. doi:10.1111/j.1365-2125.2005.02391.x
Ryan C, O’Mahony D, Kennedy J, Weedle P, Byrne S (2009) Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol 68(6):936–947. doi:10.1111/j.1365-2125.2009.03531.x
Maio V, Del Canale S, Abouzaid S (2010) Using explicit criteria to evaluate the quality of prescribing in elderly Italian outpatients: a cohort study. J Clin Pharm Ther 35(2):219–229. doi:10.1111/j.1365-2710.2009.01094.x
Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, Schroll M, Onder G, Sorbye LW, Wagner C, Reissigova J, Bernabei R, Ad HOC PRG (2005) Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293(11):1348–1358
Straand J, Rokstad KS (1999) Elderly patients in general practice: diagnoses, drugs and inappropriate prescriptions. A report from the More & Romsdal Prescription Study. Fam Pract 16(4):380–388
Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, Meyer GS (2001) Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. [See comment]. JAMA 286(22):2823–2829
Brekke M, Rognstad S, Straand J, Furu K, Gjelstad S, Bjorner T, Dalen I (2008) Pharmacologically inappropriate prescriptions for elderly patients in general practice: how common? Baseline data from The Prescription Peer Academic Detailing (Rx-PAD) study. Scand J Prim Health Care 26(2):80–85
Carey IM, De Wilde S, Harris T, Victor C, Richards N, Hilton SR, Cook DG (2008) What factors predict potentially inappropriate primary care prescribing in older people? Analysis of UK primary care patient record database. Drugs Aging 25(8):693–706. doi:2586
Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D (2011) Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 171(11):1013–1019. doi:10.1001/archinternmed.2011.215
Fu AZ, Liu GG, Christensen DB (2004) Inappropriate medication use and health outcomes in the elderly. J Am Geriatr Soc 52(11):1934–1939. doi:10.1111/j.1532-5415.2004.52522.x
Stockl KM, Le L, Zhang S, Harada AS (2010) Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Manag Care 16(1):e1–e10
Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J (2009) The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care 27(3):153–159. doi:10.1080/02813430902992215
Furu K (2008) Establishment of the nationwide Norwegian Prescription Database (NorPD)—new opportunities for research in pharmacoepidemiology in Norway. Nor Epidemiol 18(2):129–136
Statistics Norway(2011) Statbank. http://statbank.ssb.no/statistikkbanken/Default_FR.asp?PXSid=0&nvl=true&PLanguage=0&tilside=selectvarval/define.asp&Tabellid=07459. Accessed March 10, 2011
WHO Collaborating Centre for Drug Statistics Methodology and The Norwegian Institute of Public Health (2011) ATC/DDD Index. http://www.whocc.no/atc_ddd_index/. Accessed March 24, 2011
Schisterman EF, Cole SR, Platt RW (2009) Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 20(4):488–495. doi:10.1097/EDE.0b013e3181a819a1
Budnitz DS, Shehab N, Kegler SR, Richards CL (2007) Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 147(11):755–765
Goulding MR (2004) Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 164(3):305–312. doi:10.1001/archinte.164.3.305
Mattison ML, Afonso KA, Ngo LH, Mukamal KJ (2010) Preventing potentially inappropriate medication use in hospitalized older patients with a computerized provider order entry warning system. Arch Intern Med 170(15):1331–1336. doi:10.1001/archinternmed.2010.244
Acknowledgments
Dr. Nyborg has had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. MD Svein Gjelstad, Mediata AS, Tønsberg, Norway developed the computer software used in the analyses in this work and was compensated for this work from the project’s funds. Dr. Gjelstad is also a researcher at the Department of Family Medicine, Institute of Health and Society, University of Oslo, Norway but has not been a part of this project group. Contributions to the study were also made by statisticians Ingvild Dalen and Magne Thoresen, both at the Department of General Practice/Family Medicine, Institute of Health and Society, University of Oslo, Norway.
Funding
The project was funded by the Allmennmedisinsk forskningsfond (AMFF), a foundation founded and sponsored by the Norwegian Medical Association. The AMFF had no role in the design, conduct, analyses, or reporting of this study.
Conflicts of interest
The authors report no conflict of interest relevant to the topic of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nyborg, G., Straand, J. & Brekke, M. Inappropriate prescribing for the elderly—a modern epidemic?. Eur J Clin Pharmacol 68, 1085–1094 (2012). https://doi.org/10.1007/s00228-012-1223-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-012-1223-8